Praxis Precision Medicines, Inc.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
PRAX$332.97+19.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net loss | $(303,268) | $(182,819) | $(123,277) |
| Change in unrealized gain (loss) on marketable securities, net of tax | (91) | 654 | 173 |
| Comprehensive loss | $(303,359) | $(182,165) | $(123,104) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.